Early seizure onset in DEPDC5-related epilepsy is linked to more severe disease, including drug resistance, intellectual disability, and brain lesions.

The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

Early-onset dementia (EOD) is associated with increased mortality, which varies with EOD subtype, according to a recent study.

Common infections such as CMV and HSV-2 are linked to domain-specific cognitive decline in community-dwelling older adults.

Overall, 13.5% of US children living in households receiving supplemental nutrition benefit programs have food insecurity.

For patients with spontaneous, nontraumatic ICH, heavy alcohol use is linked to a hypertensive cerebral small vessel disease pattern.

Eli Lilly has made the decision to discontinue manufacturing its migraine therapy Reyvow (lasmiditan), according to the FDA’s Drug Shortages tracker.

There is a bidirectional association between myocardial infarction and late-onset epilepsy, according to a recent study.

The FDA has accepted for Priority Review the sBLA for pegvaliase-pqpz in adolescents aged 12 to 17 years with phenylketonuria.

Long-term melatonin use for treatment of insomnia is associated with a higher risk for incident heart failure and all-cause mortality.

Post-TBI sleep disturbances are linked to altered axonal integrity, disrupted brain connectivity, and abnormal EEG activity.

Patients with different subtypes of metabolic syndrome experience varying prevalence rates of stroke and ischemic heart disease.